Untitled Document

Activity Overview

This Webcast contains video and downloadable slides from Perplexing Questions in Early Breast Cancer: Answers from the Experts, a Satellite Symposium held at the 12th St Gallen International Breast Cancer Conference.

Faculty

Chair and Moderator

Martine Piccart, MD, PhD
Institute Jules Bordet
Brussels, Belgium

Faculty

Angelo Di Leo, MD, PhD
Hospital of Prato
Istituto Toscano Tumori
Prato, Italy

Michael Gnant, MD
Medical University of Vienna
Vienna, Austria

Cliff Hudis, MD
Memorial Sloan-Kettering Cancer Center
New York, New York,
United States

Christian Jackisch, MD, PhD
Klinikum Offenbach
Offenbach, Germany

 

Expert Discussion

 

Downloadable Slides



Video and downloadable slides

Topics

Bone-targeted therapy for breast cancer: Where do we stand now?
Michael Gnant, MD

Gene expression profiling for early breast cancer: Why and for whom?
Christian Jackisch, MD, PhD

What have we learned from neoadjuvant strategies for HER2-amplified breast cancer and how should we apply it?
Angelo Di Leo, MD, PhD

How can we efficiently move promising treatment strategies from the metastatic to the adjuvant setting?
Cliff Hudis, MD

Target Audience

This educational activity is designed for medical oncologists, radiation oncologists, surgical oncologists, pathologists, and other healthcare providers involved and/or interested in the management of patients with breast cancer

The information in this activity is intended for healthcare professionals based outside of the United States. You will be asked to provide your credentials before accessing the Webcast and slides. This activity may contain information on products outside the approved indications where you practice.





Printed Materials

Support

Financial support for this activity has been provided by Amgen Europe GmbH, Eisai Europe Limited, F. Hoffman-La Roche Ltd, Genomic Health, Inc and GlaxoSmithKline Oncology.

amgen

eisai

roche

genomic health

gsk